$1.08
$0.00 (0.00%)
End-of-day quote: 05/15/2024
NasdaqCM:ABVC
ABVC BioPharma Annual Report
| Year | Year | 2020 | ||
|---|---|---|---|---|
| Rev. | Revenue |
|
$0.48M | |
| GM % | Gross Margin % |
|
96.13% | |
| OM | Operating Margin |
|
0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-4.49 |
| Div. | Dividends |
|
$0.00 | |
| PR % | Payout Ratio % |
|
0 | |
| Sha. | Shares |
|
24.15m | |
| OCF | Operating Cash Flow |
|
$-5.54M | |
| FCF | Free Cash Flow |
|
$0.00M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.28 |
